Health
Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine–elicited human sera – Science
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B1.1.7 (VOC 202012/01) variant that emerged in late 2020 in the United Kingdom has many changes…
Abstract
Recently, a new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lineage called B.1.1.7 (variant of concern: VOC 202012/01), which is reported to spread more efficiently and faster than other strains, emerged in the United Kingdom. This variant has an unusually large number of mutations, with 10 amino acid changes in the spike (S) protein, raising concerns that its recognition by neutralizing antibodies may be affected. In this study, we tested SARS-CoV-2-S pseudoviruses bearing…
-
Business22 hours ago10 high-conviction ASX dividend shares to buy for passive income today
-
Noosa News24 hours agoFarmers call for policy reform across multiple sectors as productivity collapses
-
Noosa News20 hours agoTrump’s trade war puts Australian beef centre stage in Shanghai
-
General19 hours agoCoomalie council dismissed by NT government after investigation finds ‘serious deficiencies’